China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday. The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11.
from Yahoo News - Latest News & Headlines https://ift.tt/2Q2kzfN
China's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday. The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug. 11.
https://ift.tt/2Q5KaUZ August 17, 2020 at 06:08AM
ليست هناك تعليقات:
إرسال تعليق